pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    avexitide acetate
    avexitide acetate
    Hypoglycemia$AMLX Amylyx Pharmaceuticals, Inc.
  • Phase 3
    avigbagene parvec
    avigbagene parvec
    Gaucher Disease Type I Spur Therapeutics Ltd
  • Phase 3
    axicabtagene ciloleucel
    Yescarta (axicabtagene ciloleucel)
    Diffuse Large B-Cell Lymphoma$GILD GILEAD SCIENCES, INC.
← prev
page 7 of 19
next →
131
Pain89
Neurology1
Phase 3
azamidugene autotemcel
azamidugene autotemcel
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Kyowa Kirin Co Ltd
  • Phase 3
    azeliragon
    azeliragon
    Coronavirus Disease 2019 (COVID-19) Cantex Pharmaceuticals Inc
  • Phase 3
    azetukalner
    azetukalner
    Partial Seizure$XENE Xenon Pharmaceuticals Inc.
  • Phase 3
    baluretgene parvec
    baluretgene parvec
    Retinitis Pigmentosa (Retinitis)$OCGN Ocugen, Inc.
  • Phase 3
    barzolvolimab
    barzolvolimab
    Chronic Urticaria$CLDX Celldex Therapeutics, Inc.
  • Phase 3
    basimglurant
    basimglurant
    Trigeminal Neuralgia (Tic Douloureux) Noema Pharma AG
  • Phase 3
    belapectin
    belapectin
    Liver Cirrhosis$GALT GALECTIN THERAPEUTICS INC
  • Phase 3
    belimumab
    Benlysta (belimumab)
    Systemic Sclerosis (Scleroderma)$GSK GSK plc
  • Phase 3
    belzupacap sarotalocan
    belzupacap sarotalocan
    Uveal Melanoma$AURA Aura Biosciences, Inc.
  • Phase 3
    bemdaneprocel
    bemdaneprocel
    Parkinson's Disease BlueRock Therapeutics LP
  • Phase 3
    bexicaserin
    bexicaserin
    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Longboard Pharmaceuticals Inc
  • Phase 3
    bezisterim
    bezisterim
    Alzheimer's Disease$BIVI BIOVIE INC.
  • Phase 3
    bifikafusp alfa + onfekafusp alfa
    Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
    Metastatic Melanoma Philogen SpA
  • Phase 3
    bimatoprost grenod
    bimatoprost grenod
    Ocular Hypertension Kowa Co Ltd
  • Phase 3
    blarcamesine hydrochloride
    blarcamesine hydrochloride
    Fragile X Syndrome$AVXL ANAVEX LIFE SCIENCES CORP.
  • Phase 3
    bomedemstat tosylate
    bomedemstat tosylate
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)$MRK Merck & Co., Inc.
  • Phase 3
    botaretigene sparoparvovec
    botaretigene sparoparvovec
    Retinitis Pigmentosa (Retinitis) Johnson & Johnson Innovative Medicine
  • Phase 3
    brelovitug
    brelovitug [INN]
    Hepatitis D$MIRM Mirum Pharmaceuticals, Inc.
  • Phase 3
    brilaroxazine hydrochloride
    brilaroxazine hydrochloride
    Schizophrenia$RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC.
  • Phase 3
    brolucizumab
    Beovu (brolucizumab)
    Proliferative Diabetic Retinopathy (PDR)$NVS NOVARTIS AG
  • Phase 3
    bucindolol hydrochloride
    Gencaro (bucindolol hydrochloride)
    Atrial Fibrillation Genvara Biopharma Inc
  • Phase 3
    buntanetap tartrate
    buntanetap tartrate
    Parkinson's Disease$ANVS Annovis Bio, Inc.
  • Phase 3
    cadisegliatin
    cadisegliatin
    Type 1 Diabetes (Juvenile Diabetes)$VTVT vTv Therapeutics Inc.
  • Phase 3
    caficrestat
    caficrestat
    Cardiomyopathy Biossil Inc
  • Phase 3
    camlipixant
    camlipixant
    Chronic Cough$GSK GSK plc
  • Phase 3
    carenoprazan hydrochloride
    carenoprazan hydrochloride
    Duodenal Ulcer Jiangsu Carephar Pharmaceutical Co Ltd
  • Phase 3
    carisbamate
    carisbamate
    Lennox-Gastaut Syndrome SK Life Science Inc